Publication | Closed Access

Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy: a retrospective cohort analysis

Chronic PhaseThrombosisChronic Myeloid LeukemiaHematological MalignancyHealth SciencesCardiovascular DiseaseMedicineHematologyMyeloid NeoplasiaOncologyRadiation OncologyAtherosclerosisPeripheral Artery DiseaseNon-tyrosine Kinase TherapyPeripheral Vascular Disease